Clinical Trials Arena on MSN
OrsoBio announces clinical trial progress for TLC-2716 metabolic therapy
The placebo-controlled, double-blind, randomised Phase I trial involved 100 healthy participants.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results